The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antibody Production Services-Global Market Insights and Sales Trends 2025
Synopsis
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
The global Antibody Production Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antibody Production Services in various end use industries. The expanding demands from the Therapeutic, Research and Diagnostic,, are propelling Antibody Production Services market. IgM, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IgG segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibody Production Services market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibody Production Services market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody Production Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibody Production Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibody Production Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody Production Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibody Production Services covered in this report include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc.
The global Antibody Production Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Global Antibody Production Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Production Services market, Segment by Type:
IgM
IgG
IgA
Other
Global Antibody Production Services market, by Application
Therapeutic
Research
Diagnostic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antibody Production Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
The global Antibody Production Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antibody Production Services in various end use industries. The expanding demands from the Therapeutic, Research and Diagnostic,, are propelling Antibody Production Services market. IgM, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IgG segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibody Production Services market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibody Production Services market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody Production Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibody Production Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibody Production Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody Production Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibody Production Services covered in this report include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc.
The global Antibody Production Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Global Antibody Production Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Production Services market, Segment by Type:
IgM
IgG
IgA
Other
Global Antibody Production Services market, by Application
Therapeutic
Research
Diagnostic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antibody Production Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Antibody Production Services
1.1 Antibody Production Services Market Overview
1.1.1 Antibody Production Services Product Scope
1.1.2 Antibody Production Services Market Status and Outlook
1.2 Global Antibody Production Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Antibody Production Services Market Size by Region (2018-2029)
1.4 Global Antibody Production Services Historic Market Size by Region (2018-2023)
1.5 Global Antibody Production Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Antibody Production Services Market Size (2018-2029)
1.6.1 North America Antibody Production Services Market Size (2018-2029)
1.6.2 Europe Antibody Production Services Market Size (2018-2029)
1.6.3 Asia-Pacific Antibody Production Services Market Size (2018-2029)
1.6.4 Latin America Antibody Production Services Market Size (2018-2029)
1.6.5 Middle East & Africa Antibody Production Services Market Size (2018-2029)
2 Antibody Production Services Market by Type
2.1 Introduction
2.1.1 IgM
2.1.2 IgG
2.1.3 IgA
2.1.4 Other
2.2 Global Antibody Production Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Antibody Production Services Historic Market Size by Type (2018-2023)
2.2.2 Global Antibody Production Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Antibody Production Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Antibody Production Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Antibody Production Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Antibody Production Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Antibody Production Services Revenue Breakdown by Type (2018-2029)
3 Antibody Production Services Market Overview by Application
3.1 Introduction
3.1.1 Therapeutic
3.1.2 Research
3.1.3 Diagnostic
3.2 Global Antibody Production Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Antibody Production Services Historic Market Size by Application (2018-2023)
3.2.2 Global Antibody Production Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Antibody Production Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Antibody Production Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Antibody Production Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Antibody Production Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Antibody Production Services Revenue Breakdown by Application (2018-2029)
4 Antibody Production Services Competition Analysis by Players
4.1 Global Antibody Production Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Production Services as of 2022)
4.3 Date of Key Players Enter into Antibody Production Services Market
4.4 Global Top Players Antibody Production Services Headquarters and Area Served
4.5 Key Players Antibody Production Services Product Solution and Service
4.6 Competitive Status
4.6.1 Antibody Production Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Antibody Production Services Products, Services and Solutions
5.1.4 Roche Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Antibody Production Services Products, Services and Solutions
5.2.4 Johnson & Johnson Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Antibody Production Services Products, Services and Solutions
5.3.4 Merck Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Antibody Production Services Products, Services and Solutions
5.4.4 Novartis Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 AbbVie
5.5.1 AbbVie Profile
5.5.2 AbbVie Main Business
5.5.3 AbbVie Antibody Production Services Products, Services and Solutions
5.5.4 AbbVie Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.5.5 AbbVie Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Antibody Production Services Products, Services and Solutions
5.6.4 Amgen Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Antibody Production Services Products, Services and Solutions
5.7.4 Pfizer Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Bayer
5.8.1 Bayer Profile
5.8.2 Bayer Main Business
5.8.3 Bayer Antibody Production Services Products, Services and Solutions
5.8.4 Bayer Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.8.5 Bayer Recent Developments
5.9 Lilly
5.9.1 Lilly Profile
5.9.2 Lilly Main Business
5.9.3 Lilly Antibody Production Services Products, Services and Solutions
5.9.4 Lilly Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.9.5 Lilly Recent Developments
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Profile
5.10.2 Bristol-Myers Squibb Main Business
5.10.3 Bristol-Myers Squibb Antibody Production Services Products, Services and Solutions
5.10.4 Bristol-Myers Squibb Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.10.5 Bristol-Myers Squibb Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Profile
5.11.2 GlaxoSmithKline Main Business
5.11.3 GlaxoSmithKline Antibody Production Services Products, Services and Solutions
5.11.4 GlaxoSmithKline Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.11.5 GlaxoSmithKline Recent Developments
5.12 Biogen
5.12.1 Biogen Profile
5.12.2 Biogen Main Business
5.12.3 Biogen Antibody Production Services Products, Services and Solutions
5.12.4 Biogen Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.12.5 Biogen Recent Developments
5.13 AstraZeneca
5.13.1 AstraZeneca Profile
5.13.2 AstraZeneca Main Business
5.13.3 AstraZeneca Antibody Production Services Products, Services and Solutions
5.13.4 AstraZeneca Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.13.5 AstraZeneca Recent Developments
5.14 Sanofi
5.14.1 Sanofi Profile
5.14.2 Sanofi Main Business
5.14.3 Sanofi Antibody Production Services Products, Services and Solutions
5.14.4 Sanofi Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.14.5 Sanofi Recent Developments
5.15 Alexion Pharmaceuticals
5.15.1 Alexion Pharmaceuticals Profile
5.15.2 Alexion Pharmaceuticals Main Business
5.15.3 Alexion Pharmaceuticals Antibody Production Services Products, Services and Solutions
5.15.4 Alexion Pharmaceuticals Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.15.5 Alexion Pharmaceuticals Recent Developments
5.16 Seattle Genetics
5.16.1 Seattle Genetics Profile
5.16.2 Seattle Genetics Main Business
5.16.3 Seattle Genetics Antibody Production Services Products, Services and Solutions
5.16.4 Seattle Genetics Antibody Production Services Revenue (US$ Million) & (2018-2023)
5.16.5 Seattle Genetics Recent Developments
6 North America
6.1 North America Antibody Production Services Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Antibody Production Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antibody Production Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antibody Production Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antibody Production Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antibody Production Services Market Dynamics
11.1 Antibody Production Services Industry Trends
11.2 Antibody Production Services Market Drivers
11.3 Antibody Production Services Market Challenges
11.4 Antibody Production Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
